Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 018777
Company: NOVO NORDISK INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NOVOLIN L INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN 100 UNITS/ML INJECTABLE;INJECTION Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/30/1983 ORIG-1 Approval Type 3 - New Dosage Form STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/07/1989 SUPPL-9 Labeling

Label is not available on this site.

09/17/1986 SUPPL-8 Labeling

Label is not available on this site.

05/07/1985 SUPPL-6 Labeling

Label is not available on this site.

02/14/1985 SUPPL-5 Labeling

Label is not available on this site.

12/05/1983 SUPPL-2 Labeling

Label is not available on this site.

11/28/1983 SUPPL-1 Labeling

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English